- Capital Cube•2 months ago
Click here to see latest analysisAkebia Therapeutics, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -25.80 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.AKBA-US‘s earnings and EBITDA are […] (Read more...) The post Akebia Therapeutics, Inc. :AKBA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 appeared first on CapitalCube.
- Associated Press•3 months ago
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 70 cents. Akebia Therapeutics shares have dropped 30 percent since the beginning of the year. In the final minutes ...
Akebia Therapeutics, Inc.NasdaqGM
After hours: 8.620.00 (0.00%) as of 4:44 PM EDT
|Bid||7.35 x 200|
|52wk Range||5.91 - 14.20|
|Day's Range||8.47 - 8.84|
|Avg Vol (3m)||244,569|
As of 4:00 PM EDT. Market closed.